T0831
Tissue plasminogen activator human
Sinónimos:
tPA
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
About This Item
MDL number:
UNSPSC Code:
12352204
NACRES:
NA.54
Productos recomendados
form
lyophilized powder
Quality Level
specific activity
≥300 KU/mg protein
mol wt
~70 kDa
impurities
HIV, HCV, and HBsAg, tested negative
UniProt accession no.
shipped in
wet ice
storage temp.
−20°C
Gene Information
human ... PLAT(5327)
¿Está buscando productos similares? Visita Guía de comparación de productos
General description
Tissue plasminogen activator (tPA) is a protease of the S1 family (trypsin family) and is found in a wide variety of mammalian tissues, especially endothelial cells. tPA is secreted as a single chain precursor, which is cleaved to a two-chain form by plasmin. Supplied in the single chain form with a molecular weight of ~70 kDa. The Tissue Plasminogen Activator (tPA) gene is mapped to human chromosome 8p11.21 and encodes a protease of 69 kDa majorly containing serine amino acid residue. It is predominantly expressed in endothelial cells.
Application
Tissue plasminogen activator has been used in a study to assess treatment risks of intracranial hemorrhage among patients with acute ischemic stroke. Tissue plasminogen activator has also been used in a study to investigate the successful treatment of early thrombosis of HeartWare left ventricular assist devices with intraventricular thrombolytics. Human tissue plasminogen activator has been used to study the effect of tyrosinase-related protein 2 (TRP-2) expression on melanin production in sheep.
Biochem/physiol Actions
tPA is a potent activator of fibrinolysis and converts plasminogen into plasmin and also initiates cell signaling. The plasminogen activation system may also be associated with degradation of amyloid fibrils. It is also known to mediate inflammatory and extracellular matrix remodeling processes and is predicted to participate in disease progression of intracranial aneurysm indicating brain vascular malformations. Upregulation of the gene is observed in aortic aneurysms.
Physical form
Lyophilized powder, from 100 mM PBS (pH 7.4), 3.5 mg/mL L-arginine, and 0.001% Tween® 80
Preparation Note
Reconstitute with dH2O to a final concentration of 1 mg/mL (e.g. 100 μg should be reconstituted in 100 μL).
Legal Information
TWEEN is a registered trademark of Croda International PLC
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Storage Class
11 - Combustible Solids
wgk_germany
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Los clientes también vieron
Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors.
Lesept F, et al.
Cell Death & Disease, 7(11), e2466-e2466 (2016)
Tissue-type plasminogen activator regulates macrophage activation and innate immunity.
Mantuano E, et al.
Blood (2017)
Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial.
Furlan A, et al.
JAMA : The Journal of the American Medical Association, 282(21), 2003-2011 (1999)
Design, synthesis, and characterization of urokinase plasminogen-activator-sensitive near-infrared reporter.
Law B, et al.
Chemistry & Biology, 11(1), 99-106 (2004)
Converting Tissue Type Plasminogen Activator into a Zymogen IMPORTANT ROLE OF Lys156.
Tachias K and Madison E L
The Journal of Biological Chemistry, 272(1), 28-31 (1997)
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico